SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CELZ

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.40-$0.04 (-8.52%)
 
Market cap
$3.06M
Insider Score
Health Score
Analyst consensus
Listed since
Nov 6, 2015
Market Cap$3.06M-85.2%
Revenue (ttm)$3.00K-50.0%
Net Income-$7.47M-25.4%
EPS-$1.92+34.0%
Shares Out7.60M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume74,892
Open$0.41
Previous Close$0.44
Day's Range$0.40 - $0.42
52-Week Range$0.40 - $4.72
Beta1.95
AnalystsBuy
Price Targetn/a
Earnings DateMar 19, 2027
-9.09% (1D)
No price history available.

About CELZ

Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

Address
211 East Osborn Road, Phoenix, AZ, 85012, US
Market Cap
3 million
Employees
4
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$140.47K
Bought
$89.74K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From CELZ’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-8.52%
5 Days
-24.55%
1 Month
-48.00%
6 Months
-83.16%
1 Year
-85.20%

$CELZ stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CELZ holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CELZ's directors and management

No SEC Form 4 activity for CELZ in the last 5 quarters.

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CELZ Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New CELZ patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CELZ from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CELZ

VXFVanguard Extended Market ETF$13.33K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CELZ’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
20
Sells
5
Buy Value
$89.74K
Distinct Buyers
2

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.